Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
0(0%)
Results Posted
43%(3 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_2
4
36%
Ph phase_4
3
27%
Ph not_applicable
2
18%
Ph phase_3
2
18%

Phase Distribution

0

Early Stage

4

Mid Stage

5

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
4(36.4%)
Phase 3Large-scale testing
2(18.2%)
Phase 4Post-market surveillance
3(27.3%)
N/ANon-phased studies
2(18.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(7)
Terminated(1)
Other(1)

Detailed Status

Completed7
Not yet recruiting2
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Phase 24 (36.4%)
Phase 32 (18.2%)
Phase 43 (27.3%)
N/A2 (18.2%)

Trials by Status

completed764%
unknown19%
terminated19%
not_yet_recruiting218%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
OTHER
Total Trials
11